journal article·2018-05-19Open access

Application of nanocarrier-based drug delivery system in treatment of oral cancer

Abhishek K. Sah, Amber Vyas, Preeti K. Suresh, Bina Gidwani

Abstract

Oral cancer includes cancer of lips, oral cavity and oropharynx. Oral cancer is the sixth most life-threatening disease affecting 65% of population. The delivery of cytotoxic chemotherapeutic anticancer drugs is a challenging task due to unfavorable properties. Both synthetic chemotherapeutic agents and herbal constituents are used in treatment of oral cancer. The purpose of present article is to overcome the limitations through concept of nanotechnology and conjugation approach. Also, it will provide better therapeutic effect and sustain long life of healthy and recovered cells. Moreover, development in this area will raise opportunities for the oncologist, researchers and pharmaceutical scientists. This review summarizes the clinical findings and patents on various oral anticancer drugs for effective pharmacotherapeutics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Nanomedicine Research Laboratory, Department of Pharmaceutics, Indian Institute of Technology (IIT-BHU), Banaras Hindu University, Varanasi, India;

Department of Pharmaceutics, University Institute of Pharmacy, Faculty of Technology, Pt. Ravishankar Shukla University, Raipur, India;

Department of Pharmacy, University of Minnesota, Minneapolis, MN, USA;

Shri Rawatpura Sarkar Institute of Pharmacy, Kumhari, Durg, India

Funding

CGCOST

References (51)

Show source-provided references
1. 10.1016/j.oraloncology.2008.06.00210.1016/j.oraloncology.2008.06.002 ↗
2. 10.1016/j.oraloncology.2008.05.02310.1016/j.oraloncology.2008.05.023 ↗
3. 10.1186/2001-1326-3-310.1186/2001-1326-3-3 ↗
4. 10.7314/APJCP.2012.13.10.519510.7314/APJCP.2012.13.10.5195 ↗
5. 10.2174/221173850266614022000462810.2174/2211738502666140220004628 ↗
6. 10.1016/0169-409X(95)00089-P10.1016/0169-409X(95)00089-P ↗
7. 10.1073/pnas.141086511110.1073/pnas.1410865111 ↗
8. Sankhyan A · J Appl Pharm Sci · 2012 · 02 · 20
9. 10.1097/CAD.0b013e328346c7d610.1097/CAD.0b013e328346c7d6 ↗
10. 10.1002/jps.2194410.1002/jps.21944 ↗
11. 10.2147/IJN.S6167010.2147/IJN.S61670 ↗
12. 10.1007/s00784-010-0434-610.1007/s00784-010-0434-6 ↗
13. 10.1016/S0959-8049(01)00171-X10.1016/S0959-8049(01)00171-X ↗
14. 10.1038/sj.bjc.660130310.1038/sj.bjc.6601303 ↗
15. 10.1007/s12030-008-9003-310.1007/s12030-008-9003-3 ↗
16. Kakde D · J Appl Pharm Sci · 2011 · 1 · 1
17. 10.1155/2012/70193210.1155/2012/701932 ↗
18. Sutradhar KB · ISRN Nanotechnol · 2014
19. Mathur M · Appl Biol Res · 2013 · 15 · 1
20. 10.1023/A:101553131908710.1023/A:1015531319087 ↗
21. Zhang J · Cancer Genom Proteom · 2006 · 3 · 147
22. 10.1016/S0169-409X(02)00044-310.1016/S0169-409X(02)00044-3 ↗
23. 10.1146/annurev.bioeng.9.060906.15202510.1146/annurev.bioeng.9.060906.152025 ↗
24. 10.1021/js960075u10.1021/js960075u ↗
25. 10.1007/s10847-008-9456-y10.1007/s10847-008-9456-y ↗
26. 10.1016/S0169-409X(98)00092-110.1016/S0169-409X(98)00092-1 ↗
27. 10.18433/J30C7D10.18433/J30C7D ↗
28. 10.1002/jps.2111110.1002/jps.21111 ↗
29. 10.1038/sj.bjc.660448310.1038/sj.bjc.6604483 ↗
30. Balaji A · Pharmacologyonline · 2009 · 1 · 1135
31. 10.1016/j.ejps.2009.09.01010.1016/j.ejps.2009.09.010 ↗
32. 10.1208/s12249-011-9631-010.1208/s12249-011-9631-0 ↗
33. 10.1158/1078-0432.CCR-07-144110.1158/1078-0432.CCR-07-1441 ↗
34. Oommen E · Indian J Pharmacol · 1999 · 31 · 279
35. Kavitha K · J Applied Pharm Sci · 2013 · 3 · 162
36. Shrikhande S, Bajaj AN, Malhotra G, et al., inventors. Cipla Limited, King, Lawrence, assignee. Pharmaceutical compositions of polymeric nanoparticles. WO2016020697 A1. 2016 Feb 11.
37. Lee SJ, Kim YH, Lee SH, et al., inventors. JW Pharmaceutical Corporation, assignee. Oxaliplatin nanoparticles and method for preparing same. US9393201 B2. 2016 Jul 19.
38. Thaxton SC, Gordon LI, Mutharasan RK, et al., inventors. Northwestern University, assignee. Lipophilic nanoparticles for drug delivery. WO2015023797 A9. 2015 Mar 7.
39. Severin E, Zykova I, Gulenko, V, et al., inventors. Unichempharm Ltd, Oy Filana Ltd, assignee. Docetaxel-based prolonged-release cancer treatment drug. US20150140109 A1. 2015 May 21.
40. Braden ARC, Vishwanatha JK, inventors. University of North Texas Health Science Center at Fort Worth, assignee. Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics. US9023395 B2. 2015 May 5.
41. Desai NP, Shiong PS, Trieu V, inventors. Abraxis Bioscience, LLC, Los Angeles, CA, USA, assignee. Nanoparticle comprising rapamycin and albumin as anticancer agent. US 8,911,786 B2. 2014 Dec 16.
42. Messersmith PB, Black KCL IV, Yi L, et al., inventors. Northwestern University, assignee. Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same. US8784895 B2. 2014 Jul 22.
43. Severin E, Zykova I, Gulenko V, inventors. Oy Filana Ltd, assignee. Docetaxel-based prolonged-release cancertreatment drug. WO2013171382 A1. 2013 Nov 21.
44. Maitra A, Pramanik D, inventors. The Johns Hopkins University, assignee. Smart polymeric nanoparticles which overcome multidrug resistance to cancer chemotherapeutics and treatment-related systemic toxicity. EP2648760 A2. 2013 Oct 16.
45. Dash AK, Trickler WJ, inventors. Creighton University, assignee. Mucoadhesive nanoparticles for cancer treatment. US8242165 B2. 2012 Aug 14.
46. Lee SJ, Kim YH, Lee SH, et al., inventors. Choongwae Pharma Corporation, assignee. Oxaliplatin nanoparticles and method for preparing same. WO2011034394 A2. 2011 Mar 24.
47. Hong SH, Chung JH, inventors. Water-soluble organometallic nanoparticles and method for preparing the same. WO2007108618 A1. 2007 Sep 27.
48. Nah JW, Jung TR, Chae SY, et al., inventors. Anti-cancer agent loaded hydrophobic bile acid conjugated hydrophilic chitosan oligosaccharide nanoparticles and preparation method thereof. WO2007086651 A1. 2007 Aug 2.
49. Prasad NP, Roy I, Bergey EJ, et al., inventors. The Research Foundation of State University of New York, assignee. Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same. CA 2513759 A1. 2004 Aug 12.
50. Liversidge GG, Liversidge E, Chester W, et al., inventors. Eastman Kodak Company, Rochester, NY, assignee. Surface modified anticancer nanoparticles. 1995. US005399363A.
51. Hallan SS · Artif Cells Nanomed Biotechnol · 2014 · 334